Product Images Montelukast

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Montelukast NDC 33342-102 by Macleods Pharmaceuticals Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

montelukast 30s

montelukast 30s

This is a description of a medication called Montelukast Sodium Tablets in 10mg strength for adults aged 15 years and older. The packaging suggests that patients should consult the included Patient Information Leaflet before use, and it also provides information on where it should be stored. The medication was manufactured for Macleods Pharma USA, Inc. in Plainsboro, NJ, and was made by Macleods Pharmaceuticals Ltd in Baddi, Himachal Pradesh, India.*

montelukast 500s

montelukast 500s

ACLEODS Montelukast sodium, USP 10.4 mg film-coated tablets are equivalent to Montelukast 10 mg, used for adults aged 15 years or older. The tablets should be stored at 20° to 25°C, with excursions up to 15° to 30°C permitted. The product container should be subdivided, repackaged into a well-closed, light-resistant container with the attached patient information leaflet. The tablets are manufactured for Macleods Pharma USA, Inc. by Macleods Pharmaceuticals Ltd. The code no. is HP/152/07.*

montelukast 90s

montelukast 90s

This is a description for Montelukast Sodium Tablets with 10 mg strength, which is intended for adults aged 15 years and older. The tablets contain Montelukast sodium, USP 10.4 mg, equivalent to Montelukast 10 mg. The usual dosage is defined in the prescribing information. The tablets are to be stored at 20° to 25°C (68° to 77°F) with permitted excursions to 15° to 30°C (59° to 86°F). The product is manufactured by Macleods Pharmaceuticals Ltd. in India and distributed by Macleods Pharma USA, Inc. in Plainsboro, NJ 08536. Pharmacies dispense the product with an attached patient information leaflet.*

montelukast-fig-1 - montelukast fig 1

montelukast-fig-1 - montelukast fig 1

The text appears to be a table showing the mean percent change from baseline for a treatment over a period of 15 weeks, with a washout period included. The two treatments listed are Placebo and Montelukast Sodium. The table includes a visual representation with a vertical line to indicate the start and end of the treatment period, and horizontal lines to represent the changes in percentage.*

montelukast-structural - montelukast structural

montelukast-structural - montelukast structural

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.